发明名称 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
摘要 The present invention provides a compound represented by general formula (I): or pharmaceutically acceptable salts thereof, wherein W is O, S(O)<SUB>m</SUB>, CH<SUB>2 </SUB>and the like; R<SUP>1 </SUP>is halogen, lower alkyl, halo-lower alkyl, CN and the like; R<SUP>3 </SUP>is hydrogen and the like; R<SUP>4 </SUP>is hydrogen, halogen, alkyl, halo-lower alkyl, substituted alkyl, aryl, aralkyl, alkoxy, substituted alkoxy, alkanoyl, aroyl, -CONR<SUP>7</SUP>(R<SUP>8</SUP>), -S(O)<SUB>m</SUB>R<SUP>9</SUP>, -SO<SUB>2</SUB>NR<SUP>7</SUP>(R<SUP>8</SUP>) and the like; R<SUP>5 </SUP>is hydrogen, halogen, alkyl, substituted alkyl and the like; A is -N(R<SUP>6</SUP>)CO-A<SUP>1</SUP>-COR<SUP>10 </SUP>and the like; pharmaceutical compositions containing them and their uses, which have a high affinity to human thyroid hormone receptors, in particular human thyroid hormone receptor beta.
申请公布号 US2005085541(A1) 申请公布日期 2005.04.21
申请号 US20040502737 申请日期 2004.07.28
申请人 SHIOHARA HIROAKI;NAKAMURA TETSUYA;KIKUCHI NORIHIKO;OZAWA TOMONAGA;KITAZAWA MAKIO 发明人 SHIOHARA HIROAKI;NAKAMURA TETSUYA;KIKUCHI NORIHIKO;OZAWA TOMONAGA;KITAZAWA MAKIO
分类号 A61K31/19;A61K31/22;A61K31/223;A61K31/225;A61K31/27;A61K31/341;A61K31/351;A61K31/40;A61K31/426;A61K31/44;A61K31/4406;A61K31/50;A61K31/5375;A61K31/54;A61P1/16;A61P3/04;A61P3/10;A61P5/14;A61P5/16;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P17/00;A61P17/06;A61P19/10;A61P25/24;A61P27/06;A61P35/00;A61P37/08;A61P43/00;C07C59/72;C07C233/25;C07C233/56;C07C235/66;C07C309/65;C07C311/29;C07C317/22;C07C323/41;C07C323/67;C07D209/08;C07D213/75;C07D213/76;C07D237/14;C07D249/12;C07D253/075;C07D257/04;C07D257/06;C07D271/06;C07D271/07;C07D277/24;C07D277/34;C07D295/13;C07D295/192;C07D295/26;C07D307/12;C07D309/06;C07D403/12;C07D413/12;C07D417/12;(IPC1-7):A61K31/24;A61K31/18;A61K31/165;A61K31/12 主分类号 A61K31/19
代理机构 代理人
主权项
地址